![Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?]()
Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?Meiners, Petra M; Vissink, Arjan; Kallenberg, Cees GM; Kroese, Frans GM; Bootsma, Hendrika · Expert Opinion on Biological Therapy · 2011